DK598686A - Acarbose, fremstilling og anvendelse deraf - Google Patents

Acarbose, fremstilling og anvendelse deraf

Info

Publication number
DK598686A
DK598686A DK598686A DK598686A DK598686A DK 598686 A DK598686 A DK 598686A DK 598686 A DK598686 A DK 598686A DK 598686 A DK598686 A DK 598686A DK 598686 A DK598686 A DK 598686A
Authority
DK
Denmark
Prior art keywords
acarbose
manufacturing
sugar
apart
prepared
Prior art date
Application number
DK598686A
Other languages
English (en)
Other versions
DK164870C (da
DK598686D0 (da
DK164870B (da
Inventor
Erich Rauenbusch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6288309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK598686(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK598686D0 publication Critical patent/DK598686D0/da
Publication of DK598686A publication Critical patent/DK598686A/da
Publication of DK164870B publication Critical patent/DK164870B/da
Application granted granted Critical
Publication of DK164870C publication Critical patent/DK164870C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/08—Deoxysugars; Unsaturated sugars; Osones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
DK598686A 1985-12-13 1986-12-12 Fremgangsmaade til fremstilling af acarbose med et acarbose-indhold paa mindst 90 vaegtprocent paa toerstofbasis, eller en vandig oploesning deraf DK164870C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853543999 DE3543999A1 (de) 1985-12-13 1985-12-13 Hochreine acarbose
DE3543999 1985-12-13

Publications (4)

Publication Number Publication Date
DK598686D0 DK598686D0 (da) 1986-12-12
DK598686A true DK598686A (da) 1987-06-14
DK164870B DK164870B (da) 1992-08-31
DK164870C DK164870C (da) 1993-01-11

Family

ID=6288309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK598686A DK164870C (da) 1985-12-13 1986-12-12 Fremgangsmaade til fremstilling af acarbose med et acarbose-indhold paa mindst 90 vaegtprocent paa toerstofbasis, eller en vandig oploesning deraf

Country Status (12)

Country Link
US (1) US4904769A (da)
EP (1) EP0226121B1 (da)
JP (2) JP2502551B2 (da)
KR (1) KR940004065B1 (da)
CN (1) CN1013866B (da)
AT (1) ATE71951T1 (da)
BG (1) BG49497A3 (da)
CA (1) CA1288768C (da)
DE (2) DE3543999A1 (da)
DK (1) DK164870C (da)
ES (1) ES2038591T3 (da)
HU (1) HU196219B (da)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293819B1 (it) * 1997-08-05 1999-03-10 Univ Massachusetts Lowell Procedimento per la preparazione di acarbosio
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
AP1224A (en) 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
KR20010075150A (ko) 1998-09-17 2001-08-09 스티븐 비. 데이비스 ａＰ2 억제제 또는 조합을 사용하여 당뇨병을 치료하는 방법
WO2001030796A1 (en) * 1999-10-28 2001-05-03 Chong Kun Dang Pharmaceutical Corp. A process for preparing acarbose with high purity
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
ES2301142T3 (es) 2000-01-21 2008-06-16 Novartis Ag Combinaciones que comprenden inhibidores de dipeptidilpeptidasa-iv y agentes antidiabeticos.
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
IL143225A (en) * 2000-05-24 2008-03-20 Pfizer Preparation of drugs containing α-amylase inhibitors to treat hyperacidity of the inner abdomen
WO2002012256A1 (en) * 2000-08-07 2002-02-14 Biogal Gyogyszergyar Rt Method for purification of acarbose
AU2001276598A1 (en) * 2000-08-07 2002-02-18 Ranbaxy Signature Llc Liquid formulation of metformin
FI20002148A (fi) * 2000-09-29 2002-03-30 Xyrofin Oy Menetelmä tuotteiden talteenottamiseksi
FI20002149A (fi) * 2000-09-29 2002-03-30 Xyrofin Oy Sakkaridien puhdistaminen kromatografisella erotuksella
FR2816840B1 (fr) * 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
US6849609B2 (en) 2001-04-10 2005-02-01 James U. Morrison Method and composition for controlled release acarbose formulations
WO2002083066A2 (en) 2001-04-11 2002-10-24 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
HRP20010792A2 (en) * 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
US6806381B2 (en) * 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
WO2003043624A1 (en) * 2001-11-16 2003-05-30 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
FR2834214B1 (fr) * 2001-12-28 2004-09-24 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
IL164221A0 (en) * 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
US20040018990A1 (en) * 2002-07-25 2004-01-29 Harvey Rosner Treatment of obesity
US20040176425A1 (en) * 2003-01-24 2004-09-09 Washburn William N. Cycloalkyl containing anilide ligands for the thyroid receptor
TW200504021A (en) * 2003-01-24 2005-02-01 Bristol Myers Squibb Co Substituted anilide ligands for the thyroid receptor
US7459474B2 (en) * 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US7371759B2 (en) * 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
KR100918322B1 (ko) 2003-11-12 2009-09-22 페노믹스 코포레이션 헤테로시클릭 보론산 화합물
US7420059B2 (en) * 2003-11-20 2008-09-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
CN1296050C (zh) * 2003-12-10 2007-01-24 浙江海正药业股份有限公司 阿卡波糖肠溶片及制备方法
EP1778220A1 (en) * 2004-07-12 2007-05-02 Phenomix Corporation Constrained cyano compounds
US7572805B2 (en) 2004-07-14 2009-08-11 Bristol-Myers Squibb Company Pyrrolo(oxo)isoquinolines as 5HT ligands
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1796687A2 (en) * 2004-09-14 2007-06-20 Elixir Pharmaceuticals, Inc. Combination therapy for controlled carbohydrate digestion
US7517991B2 (en) * 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
WO2006076598A2 (en) * 2005-01-12 2006-07-20 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US7368458B2 (en) * 2005-01-12 2008-05-06 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076569A2 (en) 2005-01-12 2006-07-20 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US7317024B2 (en) 2005-01-13 2008-01-08 Bristol-Myers Squibb Co. Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2006078697A1 (en) * 2005-01-18 2006-07-27 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
WO2006086464A2 (en) * 2005-02-10 2006-08-17 Bristol-Myers Squibb Company Dihydroquinazolinones as 5ht modulators
US7888381B2 (en) 2005-06-14 2011-02-15 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
US7317012B2 (en) * 2005-06-17 2008-01-08 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoind-1 receptor modulators
TW200726765A (en) * 2005-06-17 2007-07-16 Bristol Myers Squibb Co Triazolopyridine cannabinoid receptor 1 antagonists
US7632837B2 (en) * 2005-06-17 2009-12-15 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid-1 receptor modulators
US20060287342A1 (en) * 2005-06-17 2006-12-21 Mikkilineni Amarendra B Triazolopyrimidine heterocycles as cannabinoid receptor modulators
US7629342B2 (en) * 2005-06-17 2009-12-08 Bristol-Myers Squibb Company Azabicyclic heterocycles as cannabinoid receptor modulators
US7452892B2 (en) * 2005-06-17 2008-11-18 Bristol-Myers Squibb Company Triazolopyrimidine cannabinoid receptor 1 antagonists
WO2007016353A2 (en) * 2005-07-28 2007-02-08 Bristol-Myers Squibb Company Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
US7795436B2 (en) * 2005-08-24 2010-09-14 Bristol-Myers Squibb Company Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
EP1931359A4 (en) * 2005-09-14 2009-04-01 Elixir Pharmaceuticals Inc COMBINATORY THERAPY FOR CONTROLLED DIGESTION OF CARBOHYDRATES
ES2445180T5 (es) 2005-09-14 2022-02-01 Takeda Pharmaceuticals Co Administración de inhibidores de dipeptidil peptidasa
AR056155A1 (es) * 2005-10-26 2007-09-19 Bristol Myers Squibb Co Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7553836B2 (en) * 2006-02-06 2009-06-30 Bristol-Myers Squibb Company Melanin concentrating hormone receptor-1 antagonists
US20070238770A1 (en) * 2006-04-05 2007-10-11 Bristol-Myers Squibb Company Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations
EP2356990A3 (en) * 2006-08-02 2011-10-19 University of Oxford Liposome treatment of viral infections
KR20090057035A (ko) * 2006-08-21 2009-06-03 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 치료를 위한 병용 요법
EP2089355A2 (en) 2006-11-01 2009-08-19 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
EP2099767A1 (en) 2006-11-01 2009-09-16 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
CN100572549C (zh) * 2007-02-01 2009-12-23 华东医药股份有限公司 高纯度阿卡波糖的制备方法
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20090011994A1 (en) * 2007-07-06 2009-01-08 Bristol-Myers Squibb Company Non-basic melanin concentrating hormone receptor-1 antagonists and methods
EP2209780B1 (en) 2007-11-01 2014-01-01 Bristol-Myers Squibb Company Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf- kappa b activity and use thereof
CA2719567A1 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
PE20091928A1 (es) * 2008-05-29 2009-12-31 Bristol Myers Squibb Co Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
SG174504A1 (en) 2009-03-27 2011-10-28 Bristol Myers Squibb Co Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
CA2757026A1 (en) * 2009-03-27 2010-09-30 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
DK2531501T3 (da) 2010-02-03 2014-02-24 Takeda Pharmaceutical Apoptosesignalregulerende kinase 1-inhibitorer
CN103153288B (zh) 2010-07-09 2017-02-15 詹姆斯·特林卡·格林 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN102030786A (zh) * 2010-11-12 2011-04-27 丽珠集团新北江制药股份有限公司 一种阿卡波糖的制备方法
EP2892897A1 (en) 2012-09-05 2015-07-15 Bristol-Myers Squibb Company Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
EP2892896B1 (en) 2012-09-05 2016-06-29 Bristol-Myers Squibb Company Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR20150127599A (ko) 2013-03-15 2015-11-17 모치다 세이야쿠 가부시키가이샤 비알코올성 지방간염을 치료하기 위한 조성물 및 방법
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN104597171A (zh) * 2013-10-31 2015-05-06 江苏万邦生化医药股份有限公司 阿卡波糖及其制剂的高效液相色谱分析方法
CN113670680A (zh) * 2021-06-30 2021-11-19 杭州中美华东制药江东有限公司 阿卡波糖杂质对照品的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
US4526784A (en) * 1981-05-05 1985-07-02 Bayer Aktiengesellschaft Amino-cyclitol derivatives and medicaments containing them
DE3123520A1 (de) * 1981-06-13 1982-12-30 Bayer Ag, 5090 Leverkusen Gesaettigte aminocyclitderivate, ihre herstellung undsie enthaltende arzneimittel
DE3439008A1 (de) * 1984-10-25 1986-04-30 Bayer Ag, 5090 Leverkusen Polymerisate zur reinigung von acarbose

Also Published As

Publication number Publication date
ATE71951T1 (de) 1992-02-15
JP2502551B2 (ja) 1996-05-29
EP0226121A3 (en) 1989-03-22
DK164870C (da) 1993-01-11
HUT43083A (en) 1987-09-28
CN86108259A (zh) 1987-07-29
JPH08245683A (ja) 1996-09-24
ES2038591T3 (es) 1993-08-01
KR870006074A (ko) 1987-07-09
BG49497A3 (en) 1991-11-15
DE3543999A1 (de) 1987-06-19
CN1013866B (zh) 1991-09-11
DK598686D0 (da) 1986-12-12
JPS62155288A (ja) 1987-07-10
EP0226121B1 (de) 1992-01-22
DE3683611D1 (de) 1992-03-05
KR940004065B1 (ko) 1994-05-11
US4904769A (en) 1990-02-27
JP2628853B2 (ja) 1997-07-09
CA1288768C (en) 1991-09-10
DK164870B (da) 1992-08-31
EP0226121A2 (de) 1987-06-24
HU196219B (en) 1988-10-28

Similar Documents

Publication Publication Date Title
DK598686A (da) Acarbose, fremstilling og anvendelse deraf
FR2583039B1 (fr) Procede de preparation du 1,2-difluorethylene et du 1-chloro-1,2-difluorethylene
GB2034307B (en) Preparation of 1,1-diesters
IT1157104B (it) Procedimento per la preparazione di derivati della 3 alcossimetilcefalosporina
IT1218065B (it) Procedimento per pa preparazione di 1,2,5,6,9,10 esabromociclododecano
AR222075A1 (es) Procedimiento de preparacion de 2',6'-dialquil-n-alcoximetil-2-cloro-acetanilida
IT1126379B (it) Procedimento per l'incisione di superfici di pezzi mediante attacco chimico
RO81506A (ro) Procedeu pentru prepararea derivatilor acizilor 1,3,4-tiadiazol-2-carboxilici
NO170922C (no) Fremgangsmaate for fremstilling av hydrogenperoksyd
IT1125604B (it) Procedimento per la preparazione di n-fenil-n'-alchilfenilendiammine
GB2036737B (en) Derivatives of 1,5-dimethylbicyclo(3,2,1)octaine
IT1128362B (it) Procedimento per la preparazione di 7 acilindolin 2 oni
IL58677A (en) Preparation of 1 alpha,3 beta-dihydroxy-delta 5-steroids and some such novel compounds
ZA792908B (en) Imidazolylethoxy derivatives of pyrazolo(3,4-b)pyridine-5-methanols
IT7950044A0 (it) Procedimento per la preparazione di 1,2-polibutadiene
IT1121013B (it) Procedimento per la preparazione della cimetidina
IT1156325B (it) Procedimento per la preparazione di amminoalchil furani o tiofeni
IT1104579B (it) Procedimento per la preparazione di miscele ferossidiche
IT7947792A0 (it) Procedimento per la preparazione di n-etiletilendiammina
GB2031422B (en) Preparation of 2,2'-bis(4-substituted-phenol sulfides
IT1207205B (it) Procedimento per la preparazione di ciclopropan-nitrili
ES516299A0 (es) "procedimiento para preparar nuevos derivados de 20,21-dinoreburnamenina".
IT1123731B (it) Procedimento per la preparazione di 1,2,3-tiadiazol-5-il-uree
DE3760049D1 (en) Use of 2,2,2-trichloro-1-phenylethanol alkyl ethers as perfumes
IT1227791B (it) Procedimento per la preparazione di 7,8 dicloro-tetraidro-isochinolina

Legal Events

Date Code Title Description
A0 Application filed
PUP Patent expired